Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Improving the Accuracy of Cancer Diagnoses

Published: Tuesday, January 08, 2013
Last Updated: Tuesday, January 08, 2013
Bookmark and Share
New spectroscopy technique could help doctors better identify breast tumors.

Tiny calcium deposits can be a telltale sign of breast cancer. However, in the majority of cases these microcalcifications signal a benign condition.  A new diagnostic procedure developed at MIT and Case Western Reserve University (CWRU) could help doctors more accurately distinguish between cancerous and noncancerous cases.

When microcalcifications are spotted through mammography, doctors perform a follow-up biopsy to remove the suspicious tissue and test it for cancer. In 15 to 25 percent of cases, however, they are unable to retrieve the tissue that contains the calcium deposits, leading to an inconclusive diagnosis. The patient then has to undergo a much more invasive surgical procedure.

The new method, which uses a special type of spectroscopy to locate microcalcifications during the biopsy, could dramatically reduce the rate of inconclusive diagnosis, according to the researchers. In a study appearing in the Proceedings of the National Academy of Sciences the week of Dec. 24, they found that the spectroscopy technique had a success rate of 97 percent.

In addition, the spectroscopic approach could easily be integrated into the current biopsy procedure, says Ishan Barman, an MIT postdoc and one of the paper’s lead authors. MIT postdocs Jaqueline Soares and Narahara Chari Dingari are also lead authors; senior authors are Maryann Fitzmaurice, senior research associate and adjunct associate professor of pathology and oncology at CWRU, and Ramachandra Rao Dasari, associate director of MIT’s Laser Biomedical Research Center (LBRC).

‘An arduous procedure’

Microcalcifications form when calcium from the bloodstream is deposited onto degraded proteins and lipids left behind by injured and dying cells. Though often seen in breast tumors, microcalcifications are rarely found in other types of cancer, Fitzmaurice says. Calcification also plays a major role in the hardening of the arteries seen in atherosclerosis.

Among women with microcalcifications spotted during a mammogram, only about 10 percent will turn out to have cancer, so the follow-up biopsy is critical. During that procedure, the radiologist first takes X-rays from three different angles to locate the microcalcifications, then inserts a needle into the tissue and removes five to 10 samples.

A pathologist then examines the tissues to see if they contain microcalcifications. If not, the radiologist tries again, after taking new X-rays. However, this second attempt is rarely successful, Fitzmaurice says.

“If they don't get them on the first pass, they usually don't get them at all,” she says. “It can become a very long and arduous procedure for the patient, with a lot of extra X-ray exposure, and in the end they still don't get what they’re after, in one out of five patients.”

For the past several years, the MIT and CWRU team has been working to develop a spectroscopic technique that can analyze the tissue that the radiologist is about to biopsy — revealing, in a matter of seconds, whether that tissue actually contains microcalcifications.

They began with Raman spectroscopy, which uses light to measure energy shifts in molecular vibrations, revealing precise molecular structures. Because it offers such detailed information about the chemical composition of a tissue, Raman spectroscopy is very accurate in identifying microcalcifications. However, the equipment required is expensive, and the analysis takes a long time.

In the new study, the researchers showed that another technique, known as diffuse reflectance spectroscopy, gives results just as accurate as Raman spectroscopy. What makes diffuse reflectance spectroscopy more appealing is that it provides information within seconds, allowing the radiologist to move the needle if it’s in the wrong spot, before taking any samples.

“With our new method, we could obtain similar results with less time and less expense,” Dingari says.

Distinctive patterns

Diffuse reflectance spectroscopy works by sending light toward the tissue, then capturing and analyzing the light after its interaction with the sample. In this study, the researchers examined 203 tissue samples from 23 patients, within minutes of those samples’ removal.

Each of the three types of tissue (healthy, lesions without microcalcifications, and lesions with microcalcifications) has subtle differences in its spectrographic signature, which can be used to distinguish among them. By analyzing these patterns, the researchers created a computer algorithm that can identify the tissues with a success rate of 97 percent.

The changes in tissues’ light absorption are likely caused by altered levels of specific proteins (elastin, desmosine and isodesmosine) that are often cross-linked with calcium deposits in diseased tissue, Soares says.

For clinical use, a radiologist would perform spectroscopy just after inserting the needle to provide enhanced real-time guidance to the current biopsy procedure. The researchers are now planning for a study in which they will test their needle and spectroscopy setup in patients as the biopsies are being done.

James Tunnell, an associate professor of biomedical engineering at the University of Texas, says the findings represent a good first step toward creating a system that could have a big impact on breast cancer diagnosis. “This technology can be integrated into the system that is already used to take biopsies. It’s a very simple technology that can get the same amount of accuracy as more complicated systems” such as Raman spectroscopy, says Tunnell, who was not involved in the study.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,100+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Achieving “Green” Desalination
Workshop explores ways to reduce or eliminate the carbon footprint of seawater desalination plants.
Thursday, October 20, 2016
Optical Fibers for Implanting in the Body
Biocompatible fibers could use light to stimulate cells or sense signs of disease.
Tuesday, October 18, 2016
New Strategy for Choosing Cancer Drugs
Device can predict tumor responses by measuring cell growth after drug exposure.
Monday, October 10, 2016
Nanosensors Could Determine Tumours’ Ability to Remodel Tissue
Researchers design nanosensors that can profile tumours, focusing on protease levels.
Thursday, September 29, 2016
High-Capacity Nanoparticles
New type of nanoparticle can now have three or more drugs packaged within it, allowing for customised cancer therapy.
Thursday, September 15, 2016
Delivering Beneficial Bacteria
Method that transports microbes through the stomach to the intestine may benefit human health.
Thursday, September 15, 2016
Linking RNA Structure and Function
Biologists have deciphered a lncRNA structure and used the information to investigate its cellular protein interactions.
Friday, September 09, 2016
Hacking Microbes
Startup’s engineered yeast helps clients produce fragrances and flavors more efficiently.
Thursday, September 08, 2016
Guided Needles Hit the Mark
New sensor could help anesthesiologists place needles for epidurals and other medical procedures.
Thursday, September 08, 2016
Changing Ocean Chemistry Due To Human Activity
More anthropogenic carbon in the northeast Pacific means weaker shells for many marine species.
Wednesday, September 07, 2016
Targeting Neglected Diseases
New enzyme-mapping advancement could help drug development for combating diseases in the developing world.
Wednesday, August 17, 2016
Protecting Privacy in Genomic Databases
System helps ensure databases used in medical research will not leak patients’ personal information.
Wednesday, August 10, 2016
Biopharmaceuticals on Demand
Portable production system would use microbes for manufacturing small amounts of vaccines and therapeutics.
Monday, August 01, 2016
Triple-Action Therapy Patch Shows Promise
Patch that delivers drug, gene, and light-based therapy to tumor sites shows promising results in mice.
Wednesday, July 27, 2016
New Device can Study Electric Field Cancer Therapy
Microfluidic device allows study of electric field cancer therapy through low-intensity fields, preventing malignant cells spreading.
Friday, July 08, 2016
Scientific News
Integrated Omics Analysis
Studying multi-omics promises to give a more holistic picture of the organism and its place in its ecosystem, however despite the complexities involved those within the field are optimistic.
Unravelling the Role of Key Genes and DNA Methylation in Blood Cell Malignancies
Researchers from the University of Nebraska Medical Center have demonstrated the role of Dnmt3a in safeguarding normal haematopoiesis.
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
Structure of Primary Cannabinoid Receptor is Revealed
The findings provide key insights into how natural and synthetic cannabinoids including tetrahydrocannabinol —a primary chemical in marijuana—bind at the CB1 receptor to produce their effects.
Overlooked Molecules Could Revolutionise our Understanding of the Immune System
Researchers have discovered that around one third of all the epitopes displayed for scanning by the immune system are a type known as ‘spliced’ epitopes.
Illumina Contributes to ClinVar Database
The contribution includes variants of all classifications, from pathogenic to benign, identified during interpretation of whole genome sequences generated in the CLIA-certified, CAP-accredited Illumina Clinical Services Laboratory.
Agilent Presents Early Career Professor Award to Dr. Roeland Verhaak
JAX professor recognized for the development and implementation of workflows for the analysis of big-data from transcriptomics to next generation sequencing approaches.
NIH Study Determines Key Differences between Allergic and Non-Allergic Dust Mite Proteins
Researchers at NIH have uncovered factors that lead to the development of dust mite allergy and assist in the design of better allergy therapies.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,100+ scientific videos